Bibliography By Topic

HIV / AIDS

Henderson, Charles. (1991, August 5). Substance boosts therapeutic effects of AZT. AIDS Weekly, 2-3.

Abstract: A complex carbohydrate compound purified from aloe vera appears to help drugs such as AZT and ACY block the pathology associated with HIV and herpes simplex virus. They also found that acemannan interfered with HIV’s ability to reproduce in infected cells.

McDaniel, H. Reginald (MD), Carpenter, Robert H. (DVM), Kemp, Maurice C. (PhD), Kahlon, Jasbir (Dr., PH), & McAnalley, Bill H. (PhD). (1989). A favorable response of HIV-1-infected patients to oral acemannan and development of prognostic criteria for clinical responsiveness.

Abstract: Reports two studies. The objective of the first was to assess response of HIV-1 patients to acemannan therapy; the objective of the second was to determine if a response to acemannan treatment could be predicted based on certain pre-therapy laboratory values. Three patients predicted to improve in all three criteria failed to do so, although they did improve in two parameters. None predicted to respond favorably failed to show some improvement. Three patients predicted to show no improvement did improve in at least one category with two of the patients improving in all three.

Pulse, T. L. (MD), & Uhlig, Elizabeth (RRA). (1990, Winter). A significant improvement in a clinical pilot study utilizing nutritional supplements, essential fatty acids and stabilized Aloe vera juice in 29 HIV seropositive, ARC and AIDS patients. Journal of Advancement in Medicine, 3(4).

Abstract: This study was concluded in November, 1989. As of June 1, 1990, all study patients from this research project who continue to be maintained on this treatment regimen have no adverse effects and only one death from K.S. Patient was non-compliant.

Sheets, Mark A.(DVM), Unger, Beverly A. (DVM), Giggleman, Gene F. Jr. (DVM), & Tizzard, Ian R. (BVMS, PhD). (1991, March). Studies on the effect of acemannan on retrovirus infections: Clinical stabilization of feline leukemia virus-infected cats. Molecular Biotherapy, 3, 41-45.

Abstract: Feline leukemia is a disease induced by an oncornavirus infection that inevitably causes clinically affected cats to die. It has been estimated that 40% of cats are dead within 4 weeks and 70% within 8 weeks of the onset of clinical symptoms. Acemannan is a complex carbohydrate with both immuno-stimulatory and direct antiviral properties. Administration of acemannan for 6 weeks intraperitoneally to clinically symptomatic cats significantly improved both the quality of life and the survival rate. Twelve weeks after initiation of treatment, 71% of treated cats were alive and in good health.

Back to Topic List

Desert Harvest 20070 Roaming Drive Colorado Springs, Colorado 80908 Toll Free: 800-222-3901 Fax: 719-598-8918 E-mail: support@desertharvest.com

Desert Harvest does not make any health claims regarding any of its products. Even though we are committed to scientific research, we are not healthcare professionals. Our products are not intended to diagnose, treat, cure, or prevent any disease. As with any good health measures, it is important for an individual to be under the routine care of a physician and to follow the directions of qualified healthcare professionals. The suggestions, statements, and products on this website have not been evaluated by the Food and Drug Administration.